• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[膀胱过度活动症的膀胱内治疗]

[Intravesical treatment of overactive bladder syndrome].

作者信息

Haferkamp A, Hohenfellner M

机构信息

Urologische Klinik, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 110, 69120, Heidelberg, Germany.

出版信息

Urologe A. 2006 Oct;45(10):1283-8. doi: 10.1007/s00120-006-1178-4.

DOI:10.1007/s00120-006-1178-4
PMID:16972089
Abstract

Overactive bladder and urgency incontinence are common conditions generally treated with oral anticholinergic medication. Despite the development of new antimuscarinic substances, many patients are refractory to or cannot tolerate the oral therapy due to severe side effects. Intravesical instillation therapy can provide an alternative method to manage detrusor overactivity. Intravesical instillation of anticholinergics such as oxybutynin and trospium chloride can achieve cholinergic blockade without producing systemic side effects. Botulinum toxin type A injections into the detrusor have been shown to increase bladder capacity and to decrease detrusor overactivity for 6 or more months. Intravesical local anesthetics such as lidocaine and bupivacaine block the conduction of unmyelinated C fibers which results in an increase of functional bladder capacity. Intravesical capsaicin and resiniferatoxin also affect the afferent C fiber innervation of the bladder, leading to a decrease in detrusor overactivity and also an increased bladder capacity. The use of intravesical anticholinergics and of local anesthetic medications, both known for their short-term efficacy, is limited due to the necessity of daily intermittent catheterization. In conclusion, intravesical therapies can provide an alternative treatment for the management of overactive bladder.

摘要

膀胱过度活动症和急迫性尿失禁是常见病症,通常采用口服抗胆碱能药物进行治疗。尽管新型抗毒蕈碱药物不断涌现,但许多患者因严重副作用而对口服治疗无效或无法耐受。膀胱内灌注疗法可为治疗逼尿肌过度活动提供一种替代方法。膀胱内灌注奥昔布宁和氯化曲司氯铵等抗胆碱能药物可实现胆碱能阻滞,且不会产生全身性副作用。向逼尿肌注射A型肉毒杆菌毒素已被证明可增加膀胱容量,并在6个月或更长时间内减少逼尿肌过度活动。膀胱内注射利多卡因和布比卡因等局部麻醉药可阻断无髓鞘C纤维的传导,从而增加功能性膀胱容量。膀胱内注射辣椒素和树脂毒素也会影响膀胱传入C纤维的神经支配,导致逼尿肌过度活动减少,膀胱容量增加。膀胱内抗胆碱能药物和局部麻醉药虽都具有短期疗效,但由于需要每日间歇性导尿,其应用受到限制。总之,膀胱内灌注疗法可为膀胱过度活动症的治疗提供一种替代方案。

相似文献

1
[Intravesical treatment of overactive bladder syndrome].[膀胱过度活动症的膀胱内治疗]
Urologe A. 2006 Oct;45(10):1283-8. doi: 10.1007/s00120-006-1178-4.
2
Intravesical therapy for overactive bladder.膀胱过度活动症的膀胱内治疗
Curr Urol Rep. 2005 Nov;6(6):429-33. doi: 10.1007/s11934-005-0037-y.
3
Intravesical treatment of overactive bladder.膀胱过度活动症的膀胱内治疗
Urology. 2000 May;55(5A Suppl):60-4; discussion 66. doi: 10.1016/s0090-4295(99)00498-7.
4
Long-term outcome of intravesical oxybutynin in children with detrusor-sphincter dyssynergia: with special reference to age-dependent parameters.膀胱内注射奥昔布宁治疗逼尿肌-括约肌协同失调患儿的长期预后:特别提及年龄相关参数
Neurourol Urodyn. 2015 Apr;34(4):336-42. doi: 10.1002/nau.22560. Epub 2014 Jan 16.
5
Botulinum toxin treatment for bladder dysfunction.肉毒杆菌毒素治疗膀胱功能障碍。
Int J Urol. 2013 Oct;20(10):956-62. doi: 10.1111/iju.12188. Epub 2013 May 2.
6
Intravesical atropine compared to oral oxybutynin for neurogenic detrusor overactivity: a double-blind, randomized crossover trial.膀胱内注射阿托品与口服奥昔布宁治疗神经源性逼尿肌过度活动的比较:一项双盲、随机交叉试验。
J Urol. 2007 Jan;177(1):208-13; discussion 213. doi: 10.1016/j.juro.2006.08.099.
7
Objective and subjective improvement in children with idiopathic detrusor overactivity after intravesical botulinum toxin injection: A preliminary report.膀胱内注射肉毒杆菌毒素后特发性逼尿肌过度活动患儿的客观和主观改善:初步报告。
J Pediatr Surg. 2019 Mar;54(3):595-599. doi: 10.1016/j.jpedsurg.2018.05.012. Epub 2018 May 21.
8
[Intravesical oxybutynin treatment for neurogenic detrusor overactivity : Efficacy and safety data from clinical practice with the first intravesical oxybutynin treatment authorized in Germany].[膀胱内注射奥昔布宁治疗神经源性逼尿肌过度活动:德国首次批准的膀胱内注射奥昔布宁治疗临床实践中的疗效和安全性数据]
Urologie. 2024 Jul;63(7):693-701. doi: 10.1007/s00120-024-02351-1. Epub 2024 May 16.
9
Botulinum toxin injections for adults with overactive bladder syndrome.肉毒杆菌毒素注射用于治疗成人膀胱过度活动症。
Cochrane Database Syst Rev. 2007 Jul 18(3):CD005493. doi: 10.1002/14651858.CD005493.pub2.
10
Intravesical botulinum type-A toxin (Dysport®) in the treatment of idiopathic detrusor overactivity in children.膀胱内注射 A 型肉毒毒素(Dysport®)治疗儿童特发性逼尿肌过度活动症。
J Pediatr Urol. 2013 Dec;9(6 Pt A):750-3. doi: 10.1016/j.jpurol.2012.08.011. Epub 2012 Oct 1.

引用本文的文献

1
[Therapy of overactive bladder (OAB)].[膀胱过度活动症(OAB)的治疗]
Urologe A. 2015 Apr;54(4):567-74; quiz 575-6. doi: 10.1007/s00120-015-3770-y.
2
Urinary incontinence in women: part 1 of a series of articles on incontinence.女性尿失禁:关于尿失禁系列文章之一。
Dtsch Arztebl Int. 2010 Jun;107(24):420-6. doi: 10.3238/arztebl.2010.0420. Epub 2010 Jun 18.

本文引用的文献

1
Intravesical oxybutynin: practicalities of clinical use.
J Obstet Gynaecol. 2006 Feb;26(2):141-3. doi: 10.1080/01443610500443477.
2
Intravesical therapy for overactive bladder.膀胱过度活动症的膀胱内治疗
Curr Urol Rep. 2005 Nov;6(6):429-33. doi: 10.1007/s11934-005-0037-y.
3
A comparison between the response of patients with idiopathic detrusor overactivity and neurogenic detrusor overactivity to the first intradetrusor injection of botulinum-A toxin.特发性逼尿肌过度活动症患者与神经源性逼尿肌过度活动症患者对首次膀胱内注射A型肉毒杆菌毒素反应的比较。
J Urol. 2005 Sep;174(3):984-9. doi: 10.1097/01.ju.0000169480.43557.31.
4
Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity.肉毒杆菌毒素膀胱逼尿肌内注射治疗人类膀胱逼尿肌过度活动后,膀胱上皮下神经纤维中感觉受体P2X3和TRPV1减少。
J Urol. 2005 Sep;174(3):977-82; discussion 982-3. doi: 10.1097/01.ju.0000169481.42259.54.
5
Botulinum-A toxin for treatment of overactive bladder without detrusor overactivity: urodynamic outcome and patient satisfaction.用于治疗无逼尿肌过度活动的膀胱过度活动症的A型肉毒毒素:尿动力学结果及患者满意度
Urology. 2005 Jul;66(1):82-7. doi: 10.1016/j.urology.2005.01.036.
6
Efficacy of botulinum-A toxin in the treatment of detrusor overactivity incontinence: a prospective nonrandomized study.A型肉毒毒素治疗逼尿肌过度活动型尿失禁的疗效:一项前瞻性非随机研究。
Am J Obstet Gynecol. 2005 May;192(5):1735-40. doi: 10.1016/j.ajog.2004.11.052.
7
Multiple intravesical instillation of low-dose resiniferatoxin is effective in the treatment of detrusor overactivity refractory to anticholinergics.低剂量树脂毒素膀胱内多次灌注治疗抗胆碱能药物难治性逼尿肌过度活动有效。
BJU Int. 2005 May;95(7):1023-7. doi: 10.1111/j.1464-410X.2005.05458.x.
8
Botulinum A toxin injections into the detrusor: an effective treatment in idiopathic and neurogenic detrusor overactivity?向逼尿肌注射A型肉毒杆菌毒素:一种治疗特发性和神经源性逼尿肌过度活动症的有效方法?
Neurourol Urodyn. 2005;24(3):231-6. doi: 10.1002/nau.20105.
9
Resiniferatoxin for detrusor instability refractory to anticholinergics.用于治疗对抗胆碱能药物难治的逼尿肌不稳定的树脂毒素。
Int Braz J Urol. 2004 Jan-Feb;30(1):53-8. doi: 10.1590/s1677-55382004000100012.
10
Bladder C-fiber desensitization induces a long-lasting improvement of BPH-associated storage LUTS: a pilot study.
Eur Urol. 2004 Jul;46(1):88-93; discussion 93-4. doi: 10.1016/j.eururo.2004.01.016.